Home/Filings/4/0001209191-21-002414
4//SEC Filing

Karnani Vikram 4

Accession 0001209191-21-002414

CIK 0001492426other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 9:09 PM ET

Size

17.4 KB

Accession

0001209191-21-002414

Insider Transaction Report

Form 4
Period: 2021-01-04
Karnani Vikram
SVP, Rheumatology Bus. Unit
Transactions
  • Award

    Ordinary Shares

    2021-01-05+65,088191,366 total
  • Award

    Restricted Stock Units (RSU)

    2021-01-04+20,95720,957 total
    Ordinary Shares (20,957 underlying)
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2021-01-0517,2600 total
    Ordinary Shares (17,260 underlying)
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2021-01-0512,09424,190 total
    Ordinary Shares (12,094 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2021-01-05+47,337126,278 total
  • Tax Payment

    Ordinary Shares

    2021-01-05$73.28/sh49,906$3,657,112141,460 total
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2021-01-0517,98317,983 total
    Ordinary Shares (17,983 underlying)
Footnotes (5)
  • [F1]Each RSU represents a contingent right to receive one ordinary share of the Issuer.
  • [F2]On January 5, 2018 and January 4, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 5, 2021, the PSUs vested as to the number of shares reported above.
  • [F3]The RSU's vest 1/3rd annually on each anniversary of January 5, 2020.
  • [F4]The RSU's vest 1/3rd annually on each anniversary of January 5, 2019.
  • [F5]The RSU's vest 1/3rd annually on each anniversary of January 5, 2018.

Issuer

Horizon Therapeutics Public Ltd Co

CIK 0001492426

Entity typeother

Related Parties

1
  • filerCIK 0001699488

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 9:09 PM ET
Size
17.4 KB